Cancellation Win For Bayer AG Over FLANAX Registration Leaves Belmora Without Relief

Bayer AG has long sold its ALEVE brand pain reliever under the FLANAX trademark outside the United States.
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Scott Slavick wrote the article, "Cancellation win for Bayer AG over FLANAX registration leaves Belmora without relief," for Inside Counsel, on June 18, 2014.

Click here to read more.

This article is intended to provide information of general interest to the public and is not intended to offer legal advice about specific situations or problems. Brinks Gilson & Lione does not intend to create an attorney-client relationship by offering this information and review of the information shall not be deemed to create such a relationship. You should consult a lawyer if you have a legal matter requiring attention. For further information, please contact a Brinks Gilson & Lione lawyer.

Cancellation Win For Bayer AG Over FLANAX Registration Leaves Belmora Without Relief

United States Intellectual Property

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More